|
TOR1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.68829999999976E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.721730E-02 |
| Normal-vs-Stage2 |
1.856150E-02 |
| Normal-vs-Stage3 |
2.022500E-03 |
| Normal-vs-Stage4 |
8.212400E-02 |
| Stage1-vs-Stage2 |
1.231400E-01 |
| Stage1-vs-Stage3 |
1.549820E-02 |
| Stage1-vs-Stage4 |
1.892400E-01 |
| Stage2-vs-Stage3 |
9.529800E-01 |
| Stage2-vs-Stage4 |
6.231600E-01 |
| Stage3-vs-Stage4 |
6.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.807640E-04 |
| Normal-vs-AfricanAmerican |
3.353700E-04 |
| Normal-vs-Asian |
3.175600E-01 |
| Caucasian-vs-AfricanAmerican |
2.857800E-01 |
| Caucasian-vs-Asian |
8.607000E-01 |
| AfricanAmerican-vs-Asian |
8.479400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.835400E-04 |
| Normal-vs-Female |
1.67998999999197E-05 |
| Male-vs-Female |
1.713990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.464300E-02 |
| Normal-vs-Extreme_Weight |
1.660210E-02 |
| Normal-vs-Obese |
2.209000E-04 |
| Normal-vs-Extreme_Obese |
5.953200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.431600E-01 |
| Normal_Weight-vs-Obese |
5.207600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.400000E-01 |
| Extreme_Weight-vs-Obese |
5.897700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.879600E-01 |
| Obese-vs-Extreme_Obese |
1.929820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.123600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.072100000587E-08 |
| Normal-vs-Age(61-80Yrs) |
2.800000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.233200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.218000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.491800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.386400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.794600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.203500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.292800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71864999999327E-05 |
| Normal-VS-Type2 PRCC |
5.542400E-02 |
| Normal-VS-KIRP CIMP |
1.097240E-03 |
| Normal-VS-Unclassified PRCC |
1.996130E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.294300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.480000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.884800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.460800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.530200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.524500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.004200E-02 |
| Normal-vs-N1 |
2.440900E-03 |
| Normal-vs-N2 |
3.529600E-01 |
| N0-vs-N1 |
3.599900E-02 |
| N0-vs-N2 |
4.953800E-01 |
| N1-vs-N2 |
7.642600E-01 |
|
|
